Evidence map›Paper›PMID 29117645›Full record

ArticleThe FEBS journal2018

Proteomic profiling of TGFBI-null mouse corneas reveals only minor changes in matrix composition supportive of TGFBI knockdown as therapy against TGFBI-linked corneal dystrophies.

Ebbe Toftgaard Poulsen, Kasper Runager, Nadia Sukusu Nielsen, Marie V Lukassen, Karen Thomsen, Paige Snider, Olga Simmons, Henrik Vorum, Simon J Conway, Jan J Enghild

Open access · bronzeAbstract read
In one paragraph

Article in The FEBS journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. [Integrating Bioinformatics and Machine Learning Algorithms to Screen Inflammatory Biomarkers for Atrial Fibrillation and Experimental Validation].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2026
    Article
  6. Precise CRISPR-Mediated Editing of theInternational journal of molecular sciences · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Ebbe Toftgaard PoulsenDepartment of Molecular Biology and Genetics, Aarhus University, Denmark.
Kasper RunagerDepartment of Molecular Biology and Genetics, Aarhus University, Denmark.
Nadia Sukusu NielsenDepartment of Molecular Biology and Genetics, Aarhus University, Denmark.
Marie V LukassenDepartment of Molecular Biology and Genetics, Aarhus University, Denmark.
Karen ThomsenInterdisciplinary Nanoscience Center, Aarhus University, Denmark.
Paige SniderHerman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN, USA.
Olga SimmonsHerman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN, USA.
Henrik VorumDepartment of Ophthalmology, Aalborg University Hospital, Denmark.
Simon J ConwayHerman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN, USA.
Jan J EnghildDepartment of Molecular Biology and Genetics, Aarhus University, Denmark.
Aarhus University · DKIndiana University School of MedicineAalborg University Hospital · DKIndiana University – Purdue University Indianapolis · US

Funding

Role of TGFbeta superfamily in Broncopulmonary DysplasiaR01HL115619 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI CONWAY, SIMON JAMES · 2013 to 2016
$1.5M
NHLBI NIH HHS R01 HL115619
6 · The paper itself

Abstract

TGFBIp is a constituent of the extracellular matrix in many human tissues including the cornea, where it is one of the most abundant proteins expressed. TGFBIp interacts with Type I, II, IV, VI, and XII collagens as well as several members of the integrin family, suggesting it plays an important role in maintaining structural integrity and possibly corneal transparency as well. Significantly, more than 60 point mutations within the TGFBI gene have been reported to result in aberrant TGFBIp folding and aggregation in the cornea, resulting in severe visual impairment and blindness. Several studies have focused on targeting TGFBIp in the cornea as a therapeutic approach to treat TGFBI-linked corneal dystrophies, but the effect of this approach on corneal homeostasis and matrix integrity remained unknown. In the current study, we evaluated the histological and proteomic profiles of corneas from TGFBI-deficient mice as well as potential redundant functions of the paralogous protein POSTN. The absence of TGFBIp in mouse corneas did not grossly affect the collagen scaffold, and POSTN is unable to compensate for loss of TGFBIp. Proteomic comparison of wild-type and TGFBI

Indexed as

AgedAged, 80 and overAnimalsCell Adhesion MoleculesCorneaCorneal Dystrophies, HereditaryEpithelial CellsExtracellular MatrixFemaleGene ExpressionHumansMaleMiceMice, KnockoutProteomicsTransforming Growth Factor betaCell Adhesion MoleculesPostn protein, mouseTransforming Growth Factor betacorneaECMiTRAQLC-MS/MSPOSTNTGFBIp

Identifiers

PMID29117645
PMCPMC5760277
OpenAlexW2767216639

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.